共 50 条
- [41] Biphasic Insulin Aspart 30 (BIAsp 30) is Safe and Improves Glycaemic Control in Insulin Naive Patients with Type 2 DiabetesJOURNAL OF DIABETES & METABOLISM, 2011, 2 (03)Esteghamati, AlirezaNakhjavani, ManouchehrAminorroaya, AshrafAboutorabi, RobabehNiafar, MitraMohammadi, MohammadParvaresh, Ehsan
- [42] Transferring patients with type 2 diabetes no longer controlled with basal human insulin to biphasic insulin aspart 30 leads to improved controlDIABETES, 2008, 57 : A562 - A563Barbonta, Diana H.Mocan, EmilianaYeo, Jing Ping
- [43] Clinical safety and effectiveness of biphasic insulin aspart 30 in type 2 diabetes patients switched from biphasic human insulin 30: Results from the Indonesian cohort of the A1chieve studyDIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 100 : S41 - S46Soewondo, PradanaLindarto, DharmaWibisono, SonyRenaldi, OllyDalem-Pemayun, Tjokorda Gde
- [44] A comparison of pharmocodynamics and pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 & Pure Insulin Aspart in type 1 diabetesDIABETES, 2007, 56 : A555 - A555Thorisdottir, Rannveig L.Parkner, TinaChen, Jian-WenEjskjaer, NielsChristiansen, Jens S.
- [45] Starting or switching to biphasic insulin aspart 30 (BIAsp 30) in type 2 diabetes: A multicenter, observational, primary care study conducted in FinlandDIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 95 (01) : 10 - 18Makela, Jyrki K.Schmuser, ChristineAskonen, KariSaukkonen, Tero
- [46] Efficacy of biphasic insulin aspart in patients with type 2 diabetesCLINICAL THERAPEUTICS, 2005, 27 : S57 - S74Halimi, SRaskin, PLiebl, AKawamori, RFulcher, GYan, G
- [48] Effect of sulfonylureas on switching to insulin therapy (twice-daily biphasic insulin aspart 30): Comparison of twice-daily biphasic insulin aspart 30 with or without glimepiride in type 2 diabetic patients poorly controlled with sub-maximal glimepirideDIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 86 (01) : 31 - 36Ebato, C.Shimizu, T.Arakawa, M.Mita, T.Fujitani, Y.Watada, H.Kawamori, R.Hirose, T.
- [49] Biphasic insulin aspart 30 combined with metformin provides better glycemic control in poorly controlled type 2 diabetic patientsDIABETES, 2002, 51 : A104 - A105Kvapil, MMikolajczyk-Swatko, AOstergaard, AHShestakova, M
- [50] Clinical pharmacological aspects of biphasic insulin aspart 50 and biphasic insulin 70 in non-obese and obese patients with type 2 diabetesDIABETOLOGIA, 2005, 48 : A305 - A305Christiansen, JSParkner, TDyrskog, SEULaursen, TMouritzen, UBrondsted, LHermansen, KLauritzen, T